Conclusions-In patients with clinically suspected coronary artery disease, FAD% discriminates between the presence or absence of coronary artery disease, whereas intimal media thickness is associated more with the extent of coronary artery disease. (Heart 1998;80:349-354) 
The most important cause of morbidity and mortality in atherosclerosis is coronary artery disease. 1 Atherosclerosis is a systemic disease and recent studies have shown a close relation between peripheral endothelial dysfunction and the presence of coronary artery disease. 2 3 Endothelial dysfunction is regarded as an early change in the development of atherosclerosis 4 5 and is thought to reflect a functional impairment of the endothelium before morphological changes can be detected. So far, methods of detecting peripheral endothelial function have been invasive and expensive. [6] [7] [8] Thus noninvasive techniques of determining endothelial function, such as flow associated vasodilatation (FAD%), are promising alternatives. [9] [10] [11] An early morphological change in atherosclerosis is the increase in intimal media thickness, which can be detected by high resolution ultrasound B mode imaging. 12 It has been shown that increased intimal media thickness in the common carotid artery is closely associated with coronary artery disease 13 and with peripheral vascular disease.
14 However, the correlation of these two features-peripheral endothelial function (that is, endothelial function of the brachial artery) and morphological changes in the common carotid artery-with the presence of coronary artery disease is not yet clearly characterised, nor has their sensitivity, specificity, and predictive value been well defined.
Our aim in this study was to analyse the diagnostic value of these non-invasive indices for the prediction of coronary artery disease. The sensitivity of FAD% and intimal media thickness was prospectively determined in patients with suspected coronary artery disease before undergoing coronary angiography.
Methods

PATIENTS
The study group consisted of 122 subjects in whom there was an indication for cardiac catheterisation for clinically suspected coronary artery disease. Thirty four were female and 88 male. Their ages ranged from 38 to 75 years (mean (SD) 60.0 (8.6) years), body mass index ranged from 20.5 to 36.7 kg/m 2 (27.0 (3.4) kg/m 2 ), and lumen diameter of the brachial artery at rest was between 2.48 and 6.33 mm (4.57 (0.74) mm). The cardiovascular risk profile was as follows: arterial hypertension (n = 69, 57%)-systolic blood pressure 136 (19) mm Hg (92 to 190), diastolic blood pressure 86 (11) mm Hg (60 to 120); hyperlipidaemia (n = 91, 75%)-total plasma cholesterol 6.2 (1.1) mmol/l (3.6 to 9.7), plasma triglyceride 2.72 (2.32) mmol/l (0.62 to 17.11); diabetes mellitus (n = 19, 16%)-fasting blood glucose 5.7 (1.3) mmol/l (4.0 to 12.3 mmol/l); smoking (n = 83, 68%)-smoking duration 25.2 (11.5) years and 17.3 (16.9) pack-years; positive family history within first degree relatives (n = 55, 45%).
The diagnosis of coronary artery disease was based on either typical clinical symptoms (n = 112, 92%), or atypical chest pain with pathological resting or stress electrocardiography, or both (n = 84, 69%). Arterial hypertension was defined as systolic blood pressure > 160 mm Hg, diastolic blood pressure > 95 mm Hg (documented at least four times), a history of arterial hypertension treated with antihypertensive agents, or combinations of these. Diabetes mellitus was defined as the use of oral hypoglycaemic agents or insulin, or as raised blood glucose concentrations according to the WHO criteria. 15 Hyperlipidaemia was defined as either being on lipid lowering drugs, or having a raised plasma total cholesterol of > 5.2 mmol/l, raised plasma triglycerides of > 2.26 mmol/l, or both (on at least two measurements). Smoking habits were documented by a standardised interview; current smoking of more than five cigarettes a day for more than three months was defined as a positive smoking history.
Patients with chronic congestive heart failure, renal insuYciency, or valvar heart disease were excluded, as were those on chronic haemodialysis or intravenous anticoagulants. All subjects were studied on their standard treatment regimens which included: aspirin 100 mg/day (n = 93, 76%), nitrates (n = 41, 34%), angiotensin converting enzyme (ACE) inhibitors (n = 26, 21%), blockers (n = 69, 57%), calcium channel antagonists (n = 26, 21%), diuretics (n = 16, 13%), and statins (n = 22, 18%).
The study was performed in accordance with the principles of the Declaration of Helsinki and was approved by the local ethics committee. Written informed consent was obtained from all participants.
STUDY PROTOCOL
One day before coronary angiography the patients were asked to refrain from smoking, drinking coVee or tea, and carrying out any exhausting physical activity six hours before the blood sampling. All blood samples were drawn two hours before the ultrasound measurements. The determination of serum total cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL), triglycerides, and blood glucose was achieved using routine laboratory methods. The next day, after at least 10 hours fasting, all patients underwent coronary angiography.
PROCEDURES
The ultrasound procedures were performed with modifications to the methods of Celermajer et al and Wendelhag et al, 9 16 as previously reported. 17 18 Briefly, the measurements were conducted in supine position at a stable room temperature of 25°C ± 2°C. The lumen diameter of the brachial artery was sought in a cross sectional view and then measured blind in longitudinal section, using B mode stand-by. Two focus zones were set to the depth of the transducer for near wall and far wall, respectively. In addition to individual optimisation of the depth and gain settings, a preset vascular imaging program was used to standardise the measurements. All scans were electrocardiographically triggered (at end diastole). Blood pressure was documented simultaneously in the contralateral arm at two minute intervals. Values are mean (SD) unless otherwise specified. Coronary artery disease classification: CAD-0, vessel alterations but lesion < 50%; CAD-1, lesion > 50% in one vessel; CAD-2, lesion > 50% in two vessels; CAD-3, lesion > 50% in three vessels. BMI, body mass index; SBP/DBP, systolic/diastolic blood pressure; CHD, coronary heart disease. Coronary artery disease classification: CAD-0, vessel alterations but lesion < 50%; CAD-1, lesion > 50% in one vessel; CAD-2, lesion > 50% in two vessels; CAD-3, lesion > 50% in three vessels. ACE inhibitors, angiotensin converting enzyme inhibitors; Ca antagonists, calcium channel antagonists.
Ultrasound measurements were taken as follows: (1) after 10 minutes of rest; (2) 45-60 seconds after sudden deflation of a tourniquet placed on the ipsilateral forearm, after whichduring a 20 minute period for vessel recoverythe intimal media thickness of the common carotid artery on both sides was determined [19] [20] [21] ; (3) a third measurement of the brachial artery was then made, after which 400 µg of glyceryl trinitrate was given sublingually; (4) four minutes later the brachial artery was scanned a fourth time to assess endothelium independent vasodilatation.
Flow associated dilatation FAD% comprises the change in arterial diameter in response to reactive hyperaemia as an endothelium dependent stimulus to vasodilatation, caused by an increase in shear stress with the release of nitric oxide. FAD% is defined as flow associated (vaso)dilatation, derived as percentage change relative to the baseline scan at rest (= 100%).
Change in arterial diameter after glyceryl trinitrate administration
The change in arterial diameter after glyceryl trinitrate administration (GTN%) was defined as the change in diameter in response to the application of 400 µg of glyceryl trinitrate, resulting in endothelium independent vasodilatation caused by relaxation of the smooth muscle cell and expressed as percentage change relative to the baseline scan (= 100%).
Intimal media thickness
The intimal media thickness of the common carotid artery was determined by methods described previously. 22 23 Briefly, we scanned the common carotid artery bilaterally and performed six diVerent blinded measurements in longitudinal projections approximately 2 cm below the bifurcation, at the start of the bulbus.
Coronary angiography
Coronary angiography was conducted using the standard Judkins technique or through the right brachial artery using the Sones technique. 24 25 Interpretation of the angiograms was performed by two diVerent observers who were blinded both for the interpretation of the angiograms and the ultrasound scores. Coronary artery disease was defined as any viewable lesion. According to the severity and extent of atherosclerosis patients were divided into five subgroups: (1) NCAD, no vessel alterations; (2) CAD-0, vessel alterations, but lesion < 50%; (3) CAD-1, lesion > 50% in one vessel; (4) CAD-2, lesions > 50% in two vessels; (5) CAD-3, lesion > 50% in three vessels.
High resolution ultrasound FAD%, GTN%, and intimal media thickness were assessed using a high resolution ultrasound device (AU4 Idea, ESAOTE Biomedica, Munich, Germany), equipped with an integrated electrocardiography package and a 13 MHz linear array transducer with an axial resolution of 0.12 mm and a penetration depth of 1.0-4.5 cm.
A continuous measurement of blood pressure by cuV inflation in two minute intervals was performed using an automatic device (Bosotron 2, Bosch und Sohn GmbH, Jungingen, Germany). Documentation of data was accomplished by a Sony videographic printer UP-890CE (Sony Corporation, Tokyo, Japan).
REPRODUCIBILITY
Intraobserver variability was determined for FAD% and GTN% on the basis of 15 measurements each. A coeYcient of variation of 1.2% to 4.2% was found. The interobserver variability was evaluated as a mean (SD) diVerence of maximum 0.18 (0.10) mm, representing a diVerence of < 0.21 mm in 95% of all measurements. The intra-and interobserver variability for the measurement of intimal media thickness was comparable. 22 
23
Figure 1 Flow associated vasodilatation (FAD%) related to the extent of coronary artery disease (CAD). NCAD, no vessel alterations; CAD-0, vessel alterations but lesion < 50%; CAD-1, lesion > 50% in one vessel; CAD-2, lesion > 50% in two vessels; CAD-3, lesion > 50% in three vessels; FAD%, flow associated (vaso)dilatation derived as percentage change during reactive hyperaemia relative to the baseline scan at rest (100%).
Figure 2 Intimal media thickness related to the extent of coronary artery disease (CAD). NCAD, no vessel alterations; CAD-0, vessel alterations, but lesion < 50%; CAD-1, lesion > 50% in one vessel; CAD-2, lesion > 50% in two vessels
; CAD-3, lesion > 50% in three vessels. group.bmj.com on June 22, 2017 -Published by http://heart.bmj.com/ Downloaded from STATISTICAL ANALYSIS Continuous variables were described using means and standard deviations (mean (SD)). Discrete variables were described as counts and percentages. The distributions of discrete variables (risk factors and clinical characteristics) by coronary artery disease group were compared using 2 tests. We used analysis of variance to compare continuous variables by coronary artery disease severity group if normally distributed, and the Kruskal-Wallis test if not normally distributed. Spearman rank correlations were used to describe correlations between variables that were not normally distributed. Test results are presented as nominal two tailed p values. Significance was inferred at p < 0.05. Because of the explorative nature of the study, all tests were interpreted in a descriptive sense.
To evaluate FAD% and intimal media thickness as a screening test for coronary artery disease the optimal cut oV point was determined by receiver operating characteristic (ROC) analysis, using the coronary angiography result as the gold standard for the diagnosis of coronary artery disease. ROC analysis applies to tests that report clinical data as a continuous range of variables. The ROC is the relation between sensitivity and specificity for diVerent test cut oV values used as criteria for detecting disease. 26 The sensitivity and specificity are presented with 95% confidence intervals.
Results
PATIENT DATA
The 122 patients were examined both by peripheral high resolution ultrasound and coronary angiography. In 21 patients coronary angiography was normal (the NCAD group). Table 1 gives the baseline characteristics and the cardiovascular profile of the five subgroups. Only triglycerides showed diVerences between the groups (p = 0.042); otherwise all five groups were comparable with respect to numbers, age, sex, body mass index, blood pressure, family history, the distribution of smoking, diabetes, and hypertension. One patient in the CAD-0 group had a plasma triglyceride concentration of 17.3 mmol/l. This resulted in the diVerence among the groups.
ULTRASOUND STUDIES
The lumen diameter at rest did not diVer between the five groups (table 2). FAD% was decreased in the four coronary artery disease groups compared with the NCAD group (3.7 (4.1)% v 7.0 (3.5)%, p < 0.001). No difference was found for FAD% between the diVerent coronary artery disease groups: CAD-0, 4.2 (3.5)%; CAD-1, 3.5 (3.9)%; CAD-2, 3.5 (4.6)%; CAD-3, 3.5 (4.8)% (fig 1) . After sublingual application of 400 µg glyceryl trinitrate, vessel dilatation in patients without angiographically detectable coronary artery disease (NCAD group) was increased in comparison with the patients with coronary artery disease (14.9 (7.4)% v 10.2 (6.8)%, p = 0.005), but without further diVerences between the coronary artery disease groups: CAD-0, 9.5 (6.1)%; CAD-1, 9.9 (8.1)%; CAD-2, 10.8 (6.0)%; CAD-3, 11.0 (7.0)%.
The intimal media thickness of the common carotid artery tended to be increased in the coronary artery disease groups compared with the NCAD group (0.59 (0.35) v 0.47 (0.11) mm, p = 0.053). Intimal media thickness increased continuously with the extent of coronary artery disease (fig 2) . We found an inverse relation between intimal media thickness and FAD% (fig 3) . ROC analysis was calculated for FAD% and intimal media thickness to characterise the ability to predict coronary artery disease from these non-invasive sonographic indices. A cut oV point of FAD% of < 4.5% with a sensitivity of 0.71 (95% confidence interval 0.61 to 0.80), a specificity of 0.81 (0.61 to 0.80), and a positive predictive value of 0.95 was determined (fig 4) . In contrast to FAD%, intimal media thickness showed a positively linear relation with coronary artery disease (fig 4) , and a cut oV point could not be calculated by ROC analysis. 
Discussion
An association between sonographic variables (such as intimal media thickness and FAD%) and coronary artery disease has recently been described. 2 3 13 The aim of this study was to evaluate and to compare the ability of the two non-invasive indices to predict coronary artery disease. The two indices diVer with regard to the pathophysiological information they provide, since FAD% is a functional variable and intimal media thickness a morphological variable. Both were correlated with the presence and extent of coronary artery disease assessed by coronary angiography.
FLOW ASSOCIATED VASODILATATION
A reduced FAD% was found in all patients with haemodynamically significant lesions by angiography compared with patients without angiographically visible lesions. This is in accordance with previously published data. 3 27 In contrast to Neunteufl et al, 27 we did not find any diVerence in FAD% between the various coronary disease patient groups. One explanation for this diVerence might be that besides age, sex, and lumen diameter other possible confounding factors for FAD% were present, such as diabetes mellitus, 28 hyperlipidaemia, 9 29 arterial hypertension, 30 smoking, 31 and a positive family history. 32 We corrected FAD% for body mass index, blood pressure, cholesterol, family history, smoking history, diabetes, and hypertension within the diVerent patient groups, which was not done by Neunteufl et al.
The ROC analysis revealed a cut oV point of FAD% of < 4.5% with a sensitivity of 0.71, a specificity of 0.81, and a positive predictive value of 0.95 for the presence of coronary artery disease. This cut oV value is similar to the value of 3% found by Anderson et al in predicting coronary endothelial dysfunction. The calculated cut oV value for FAD% in the study by Neunteufl et al was 10% with a sensitivity of about 85% and a specificity comparable to our results. 27 The most probable reason for a small cut oV point and generally smaller FAD% and GTN% values in our study is that our measurements were performed without discontinuing the patients' drug treatment, which may have influenced endothelial dependent and independent vasodilatation. It is, however, of interest that this did not result in significant diVerences in mean FAD% within the different patient groups. Another reason may be that a diVerent definition of the lumen diameter was used in our study. According to the definition of Wendelhag et al, 16 the A line (intima/lumen interface at the near wall) was visualised and the actual morphological lumen diameter determined by measuring the distance between the A line and the B line. This was diVerent from the study by Neunteufl et al, 27 where the lumen diameter was measured as the difference between the two M lines.
INTIMAL MEDIA THICKNESS
We found a trend towards increased intimal media thickness in patients with coronary artery disease compared with the group without angiographic coronary artery disease. There was a positive correlation between the intimal media thickness of the common carotid artery and the extent of coronary artery disease. These findings are in agreement with other recent studies. 33 34 In addition, our results showed an inverse relation between intimal media thickness and FAD% within the same cohort of patients with coronary artery disease. In the patients with coronary artery disease we found a continuous linear correlation between intimal media thickness of the common carotid artery and coronary artery disease, and thus-in contrast to Visona and colleagues 34 -we were unable to calculate a cut oV point for intimal media thickness to predict the presence of coronary artery disease. Our data support the hypothesis of Adams et al, 33 that the measurement of intimal media thickness is not suYcient for screening patients with suspected coronary artery disease.
CHANGE IN ARTERIAL DIAMETER AFTER GLYCERYL TRINITRATE
It has been shown previously that determination of GTN% is an index of reduced nitric oxide sensitivity in the smooth muscle cell of the arterial wall. We found a reduced GTN% in patients with coronary artery disease compared with patients with angiographically normal coronary arteries. This is in agreement with the study by Neunteufl et al, 27 who also described a reduced GTN% in coronary artery disease patients. These findings suggest that more advanced coronary atherosclerosis is associated with systemic atherosclerosis presenting with dysfunction of the smooth muscle cells of the peripheral arterial system. 24 
STUDY LIMITATIONS
A certain preselection bias needs to be taken into account in interpreting these data, since all patients were scheduled for coronary angiography by expert cardiologists as a result of symptoms typical of coronary artery disease. 35 Thus all the ultrasound measurements were performed without discontinuing concurrent drug treatment (table 3) . However, the diVerent patient groups were quite well matched for drug treatment distribution, and concurrent medication did not significantly influence the results of FAD% and intimal media thickness (table 3) . 
CONCLUSION
Our data indicate that an impaired FAD% may be an useful non-invasive marker of the presence of coronary artery disease in patients with clinically suspect coronary artery disease. In contrast, determination of increased intimal media thickness is not useful in discriminating between presence or absence of coronary artery disease, though in patients with coronary artery disease, it appears to be associated with the extent of the disease. The role of these ultrasound procedures in the management of patients with chest pain in comparison with established non-invasive diagnostic tools (for example, electrocardiography, stress electrocardiography, nuclear myocardial scintigraphy) remains to be evaluated.
